Title: Application of Innovative Technologies to Advance the Development of Novel Pharmaceutics
To download the abstract, please click here
Margaret received her Ph.D. degree in Synthetic Organic Chemistry from Harvard University. She currently works at Amgen Inc, in Thousand Oaks, CA where she is Vice President of Manufacturing and Clinical Supply and the Amgen Thousand Oaks Operations Site Head.
Margaret has supported drug development programs across all phases of clinical and commercial. She has experience working with commercial manufacturing organizations worldwide and has invested significant effort in evolving a green chemistry culture in the workplace. As a result, Amgen was awarded in 2017 the Presidential Green Chemistry Challenge Award for developing an improved green process for commercial manufacture of Parsabiv®. Margaret has a strong external presence. She was chair of the Board of Directors of the International Consortium for Innovation and Quality in the Pharmaceutical Industry and past chair and founder of the Enabling Technologies Consortium.
Margaret has authored/co-authored more than 150 peer reviewed publications, presentations, and patents, and has served as a symposium organizer and session chair for several major process chemistry events. She is an associate editor for Organic Letters and is a member of the editorial boards for Science of Synthesis, Organic Syntheses, Synthesis and SynLett, and Advanced Synthesis and Catalysis. In partnership with Thiéme and the Science of Synthesis, she sponsors the Dr. Margaret Faul Award for Women in the Chemical Sciences.